Rheumatology Flashcards

1
Q

Ankylosing spondylitis: features

A

Ankylosing spondylitis features - the ‘A’s

Apical fibrosis

Anterior uveitis

Aortic regurgitation

Achilles tendonitis

AV node block

Amyloidosis

Ankylosing spondylitis is a HLA-B27 associated spondyloarthropathy. It typically presents in males (sex ratio 3:1) aged 20-30 years old.

Features

typically a young man who presents with lower back pain and stiffness of insidious onset

stiffness is usually worse in the morning and improves with exercise

the patient may experience pain at night which improves on getting up

Clinical examination

reduced lateral flexion

reduced forward flexion - Schober’s test - a line is drawn 10 cm above and 5 cm below the back dimples (dimples of Venus). The distance between the two lines should increase by more than 5 cm when the patient bends as far forward as possible

reduced chest expansion

Other features - the ‘A’s

Apical fibrosis

Anterior uveitis

Aortic regurgitation

Achilles tendonitis

AV node block

Amyloidosis

and cauda equina syndrome

peripheral arthritis (25%, more common if female)

Ankylosing spondylitis investigation and management

Ankylosing spondylitis is a HLA-B27 associated spondyloarthropathy. It typically presents in males (sex ratio 3:1) aged 20-30 years old.

Investigation

Inflammatory markers (ESR, CRP) are typically raised although normal levels do not exclude ankylosing spondylitis.

HLA-B27 is of little use in making the diagnosis as it is positive in:

90% of patients with ankylosing spondylitis

10% of normal patients

Plain x-ray of the sacroiliac joints is the most useful investigation in establishing the diagnosis. Radiographs may be normal early in disease, later changes include:

sacroiliitis: subchondral erosions, sclerosis

squaring of lumbar vertebrae

‘bamboo spine’ (late & uncommon)

syndesmophytes: due to ossification of outer fibers of annulus fibrosus

chest x-ray: apical fibrosis

If the x-ray is negative for sacroiliac joint involvement in ankylosing spondylitis but suspicion for AS remains high, the next step in the evaluation should be obtaining an MRI. Signs of early inflammation involving sacroiliac joints (bone marrow oedema) confirm the diagnosis of AS and prompt further treatment.

Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis and ankylosis of the costovertebral joints.

Management

The following is partly based on the 2010 EULAR guidelines (please see the link for more details):

encourage regular exercise such as swimming

NSAIDs are the first-line treatment

physiotherapy

the disease-modifying drugs which are used to treat rheumatoid arthritis (such as sulphasalazine) are only really useful if there is peripheral joint involvement

the 2010 EULAR guidelines suggest: ‘Anti-TNF therapy should be given to patients with persistently high disease activity despite conventional treatments’

research is ongoing to see whether anti-TNF therapies such as etanercept and adalimumab should be used earlier in the course of the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rheumatoid arthritis: antibodies

A

Rheumatoid factor

Rheumatoid factor (RF) is a circulating antibody (usually IgM) which reacts with the Fc portion of the patients own IgG.

RF can be detected by either

Rose-Waaler test: sheep red cell agglutination

Latex agglutination test (less specific)

RF is positive in 70-80% of patients with rheumatoid arthritis, high titre levels are associated with severe progressive disease (but NOT a marker of disease activity)

Other conditions associated with a positive RF include:

Sjogren’s syndrome (around 100%)

Felty’s syndrome (around 100%)

infective endocarditis (= 50%)

SLE (= 20-30%)

systemic sclerosis (= 30%)

general population (= 5%)

rarely: TB, HBV, EBV, leprosy

Anti-cyclic citrullinated peptide antibody

Anti-cyclic citrullinated peptide antibody may be detectable up to 10 years before the development of rheumatoid arthritis. It may therefore play a key role in the future of rheumatoid arthritis, allowing early detection of patients suitable for aggressive anti-TNF therapy. It has a sensitivity similar to rheumatoid factor (around 70%) with a much higher specificity of 90-95%.

NICE recommends that patients with suspected rheumatoid arthritis who are rheumatoid factor negative should be test for anti-CCP antibodies.

Rheumatoid arthritis: x-ray changes

Early x-ray findings

loss of joint space

juxta-articular osteoporosis

soft-tissue swelling

Late x-ray findings

periarticular erosions

subluxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antiphospholipid syndrome

A

Antiphospholipid syndrome is an acquired disorder characterised by a predisposition to both venous and arterial thromboses, recurrent fetal loss and thrombocytopenia. It may occur as a primary disorder or secondary to other conditions, most commonly systemic lupus erythematosus (SLE)

A key point for the exam is to appreciate that antiphospholipid syndrome causes a paradoxical rise in the APTT. This is due to an ex-vivo reaction of the lupus anticoagulant autoantibodies with phospholipids involved in the coagulation cascade

Features

venous/arterial thrombosis

recurrent fetal loss

livedo reticularis

thrombocytopenia

prolonged APTT

other features: pre-eclampsia, pulmonary hypertension

Associations other than SLE

other autoimmune disorders

lymphoproliferative disorders

phenothiazines (rare)

Management - based on BCSH guidelines

initial venous thromboembolic events: evidence currently supports use of warfarin with a target INR of 2-3 for 6 months

recurrent venous thromboembolic events: lifelong warfarin; if occurred whilst taking warfarin then increase target INR to 3-4

arterial thrombosis should be treated with lifelong warfarin with target INR 2-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dermatomyositis

A

an inflammatory disorder causing symmetrical, proximal muscle weakness and characteristic skin lesions

may be idiopathic or associated with connective tissue disorders or underlying malignancy (typically ovarian, breast and lung cancer, found in 20-25% - more if patient older). Screening for an underlying malignancy is usually performed following a diagnosis of dermatomyositis

polymyositis is a variant of the disease where skin manifestations are not prominent

Skin features

photosensitive

macular rash over back and shoulder

heliotrope rash in the periorbital region

Gottron’s papules - roughened red papules over extensor surfaces of fingers

‘mechanic’s hands’: extremely dry and scaly hands with linear ‘cracks’ on the palmar and lateral aspects of the fingers

nail fold capillary dilatation

Other features

proximal muscle weakness +/- tenderness

Raynaud’s

respiratory muscle weakness

interstitial lung disease: e.g. Fibrosing alveolitis or organising pneumonia

dysphagia, dysphonia

Investigations

the majority of patients (around 80%) are ANA positive

around 30% of patients have antibodies to aminoacyl-tRNA synthetases (anti-synthetase antibodies), including:

antibodies against histidine-tRNA ligase (also called Jo-1)

antibodies to signal recognition particle (SRP)

anti-Mi-2 antibodies

This is a description of the typical skin changes seen in dermatomyositis, a connective tissue disease. In addition to the plaques on the knuckles (Gottron’s papules) and eyelids (heliotrope rash) there may be scaling of the scalp and changes to the nail beds and cuticles. There is inflammation of the proximal muscles causing weakness, but the skin changes often are the first presenting feature. Dermatomyositis is usually an autoimmune condition, in which case it is controlled with immunosuppressants, but may also be a paraneoplastic syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Systemic lupus erythematosus: features

A

Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disorder. It typically presents in early adulthood and is more common in women and people of Afro-Caribbean origin.

General features

fatigue

fever

mouth ulcers

lymphadenopathy

Skin

malar (butterfly) rash: spares nasolabial folds

discoid rash: scaly, erythematous, well demarcated rash in sun-exposed areas. Lesions may progress to become pigmented and hyperkeratotic before becoming atrophic

photosensitivity

Raynaud’s phenomenon

livedo reticularis

non-scarring alopecia

Musculoskeletal

arthralgia

non-erosive arthritis

Cardiovascular

pericarditis: the most common cardiac manifestation

myocarditis

Respiratory

pleurisy

fibrosing alveolitis

Renal

proteinuria

glomerulonephritis (diffuse proliferative glomerulonephritis is the most common type)

Neuropsychiatric

anxiety and depression

psychosis

seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drug-induced lupus

A

In drug-induced lupus not all the typical features of systemic lupus erythematosus are seen, with renal and nervous system involvement being unusual. It usually resolves on stopping the drug.

Features

arthralgia

myalgia

skin (e.g. malar rash) and pulmonary involvement (e.g. pleurisy) are common

ANA positive in 100%, dsDNA negative

anti-histone antibodies are found in 80-90%

anti-Ro, anti-Smith positive in around 5%

A woman with drug-induced lupus
Most common causes

procainamide

hydralazine

Less common causes

isoniazid

minocycline

phenytoin

Gottron’s papules, roughened red papules over the knuckles mainly, are seen in dermatomyositis

This patient may have dermatomyositis. She is describing muscle weakness with associated skin changes. Gottron’s papules are erythematous, keratotic macules overlying her interphalangeal joints and they are seen in dermatomyositis.

It is osteoarthritis that is linked to Bouchard’s and Heberden’s nodes. They present as painless swellings of the proximal and distal interphalangeal joints respectively.

Osler nodes and janeway lesions are associated with endocarditis and present as macular lesions on the palms. Osler nodes are painful and due to immune complex deposition whereas janeway lesions are painless and due to septic emboli.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Gout management

A

Gout is a form of microcrystal synovitis caused by the deposition of monosodium urate monohydrate in the synovium. It is caused by chronic hyperuricaemia (uric acid > 450 µmol/l)

Acute management

NSAIDs or colchicine are first-line

the maximum dose of NSAID should be prescribed until 1-2 days after the symptoms have settled. Gastroprotection (e.g. a proton pump inhibitor) may also be indicated

colchicine* has a slower onset of action. The main side-effect is diarrhoea

oral steroids may be considered if NSAIDs and colchicine are contraindicated. A dose of prednisolone 15mg/day is usually used

another option is intra-articular steroid injection

if the patient is already taking allopurinol it should be continued

Indications for urate-lowering therapy (ULT)

the British Society of Rheumatology Guidelines now advocate offering urate-lowering therapy to all patients after their first attack of gout

ULT is particularly recommended if:

→ >= 2 attacks in 12 months

→ tophi

→ renal disease

→ uric acid renal stones

→ prophylaxis if on cytotoxics or diuretics

Urate-lowering therapy

allopurinol is first-line

it has traditionally been taught that urate-lowering therapy should not be started until 2 weeks after an acute attack, as starting too early may precipitate a further attack. The evidence base to support this however looks weak

in 2017 the BSR updated their guidelines. They still support a delay in starting urate-lowering therapy because it is better for a patient to make long-term drug decisions whilst not in pain

initial dose of 100 mg od, with the dose titrated every few weeks to aim for a serum uric acid of < 300 µmol/l. Lower initial doses should be given if the patient has a reduced eGFR

colchicine cover should be considered when starting allopurinol. NSAIDs can be used if colchicine cannot be tolerated. The BSR guidelines suggest this may need to be continued for 6 months

the second-line agent when allopurinol is not tolerated or ineffective is febuxostat (also a xanthine oxidase inhibitor)

in refractory cases other agents may be tried:

uricase (urate oxidase) is an enzyme that catalyzes the conversion of urate to the degradation product allantoin. It is present in certain mammals but not humans

in patients who have persistent symptomatic and severe gout despite the adequate use of urate-lowering therapy, pegloticase (polyethylene glycol modified mammalian uricase) can achieve rapid control of hyperuricemia. It is given as an infusion once every two weeks

Lifestyle modifications

reduce alcohol intake and avoid during an acute attack

lose weight if obese

avoid food high in purines e.g. Liver, kidneys, seafood, oily fish (mackerel, sardines) and yeast products

Other points

consideration should be given to stopping precipitating drugs (such as thiazides)

losartan has a specific uricosuric action and may be particularly suitable for the many patients who have coexistent hypertension

increased vitamin C intake (either supplements or through normal diet) may also decrease serum uric acid levels

*inhibits microtubule polymerization by binding to tubulin, interfering with mitosis. Also inhibits neutrophil motility and activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gout: drug causes

A

Gout is a form of microcrystal synovitis caused by the deposition of monosodium urate monohydrate in the synovium. It is caused by chronic hyperuricaemia (uric acid > 0.45 mmol/l).

Drug causes

diuretics: thiazides, furosemide

ciclosporin

alcohol

cytotoxic agents

pyrazinamide

aspirin: it was previously thought that only high-dose aspirin could precipitate gout. However, a systematic review (see link) showed that low-dose (e.g. 75mg) also increases the risk of gout attacks. This obviously needs to be balanced against the cardiovascular benefits of aspirin and the study showed patients coprescribed allopurinol were not at an increased risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pseudogout

A

Pseudogout is a form of microcrystal synovitis caused by the deposition of calcium pyrophosphate dihydrate crystals in the synovium.

Risk factors

haemochromatosis

hyperparathyroidism

acromegaly

low magnesium, low phosphate

Wilson’s disease

Features

knee, wrist and shoulders most commonly affected

joint aspiration: weakly-positively birefringent rhomboid-shaped crystals

x-ray: chondrocalcinosis

in the knee this can be seen as linear calcifications of the meniscus and articular cartilage

Management

aspiration of joint fluid, to exclude septic arthritis

NSAIDs or intra-articular, intra-muscular or oral steroids as for gout

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hip pain in adults

A

The table below provides a brief summary of the potential causes of hip pain in adults

Condition

Features

Osteoarthritis

Pain exacerbated by exercise and relieved by rest
Reduction in internal rotation is often the first sign
Age, obesity and previous joint problems are risk factors

Inflammatory arthritis

Pain in the morning
Systemic features
Raised inflammatory markers

Referred lumbar spine pain

Femoral nerve compression may cause referred pain in the hip
Femoral nerve stretch test may be positive - lie the patient prone. Extend the hip joint with a straight leg then bend the knee. This stretches the femoral nerve and will cause pain if it is trapped

Greater trochanteric pain syndrome (Trochanteric bursitis)

Due to repeated movement of the fibroelastic iliotibial band
Pain and tenderness over the lateral side of thigh
Most common in women aged 50-70 years

Meralgia paraesthetica

Caused by compression of lateral cutaneous nerve of thigh
Typically burning sensation over antero-lateral aspect of thigh

Avascular necrosis

Symptoms may be of gradual or sudden onset
May follow high dose steroid therapy or previous hip fracture of dislocation

Pubic symphysis dysfunction

Common in pregnancy
Ligament laxity increases in response to hormonal changes of pregnancy
Pain over the pubic symphysis with radiation to the groins and the medial aspects of the thighs. A waddling gait may be seen

Transient idiopathic osteoporosis

An uncommon condition sometimes seen in the third trimester of pregnancy
Groin pain associated with a limited range of movement in the hip
Patients may be unable to weight bear
ESR may be elevated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hydroxychloroquine

A

Hydroxychloroquine is used in the management of rheumatoid arthritis and systemic/discoid lupus erythematosus. It is pharmacologically very similar to chloroquine which is used to treat certain types of malaria.

Adverse effects

bull’s eye retinopathy - may result in severe and permanent visual loss

recent data suggest that retinopathy caused by hydroxychloroquine is more common than previously thought and the most recent RCOphth guidelines (March 2018) suggest colour retinal photography and spectral domain optical coherence tomography scanning of the macula

baseline ophthalmological examination and annual screening is generally recommened

A contrast to many drugs used in rheumatology, hydroxychloroquine may be used if needed in pregnant women.

Monitoring

the BNF advises: ‘Ask patient about visual symptoms and monitor visual acuity annually using the standard reading chart’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hypersensitivity

A

Hypersensitivity

The Gell and Coombs classification divides hypersensitivity traditionally divides reactions into 4 types:

Type

Mechanism

Examples

Type I - Anaphylactic

Antigen reacts with IgE bound to mast cells

  • Anaphylaxis
  • Atopy (e.g. asthma, eczema and hayfever)

Type II - Cell bound

IgG or IgM binds to antigen on cell surface

  • Autoimmune haemolytic anaemia
  • ITP
  • Goodpasture’s syndrome
  • Pernicious anaemia
  • Acute haemolytic transfusion reactions
  • Rheumatic fever
  • Pemphigus vulgaris / bullous pemphigoid

Type III - Immune complex

Free antigen and antibody (IgG, IgA) combine

  • Serum sickness
  • Systemic lupus erythematosus
  • Post-streptococcal glomerulonephritis
  • Extrinsic allergic alveolitis (especially acute phase)

Type IV - Delayed hypersensitivity

T-cell mediated

  • Tuberculosis / tuberculin skin reaction
  • Graft versus host disease
  • Allergic contact dermatitis
  • Scabies
  • Extrinsic allergic alveolitis (especially chronic phase)
  • Multiple sclerosis
  • Guillain-Barre syndrome

In recent times a further category has been added:

Type V

Antibodies that recognise and bind to the cell surface receptors.

This either stimulating them or blocking ligand binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Septic arthritis

A

Septic arthritis

raised WCC

Management

synovial fluid should be obtained before starting treatment

intravenous antibiotics which cover Gram-positive cocci are indicated. The BNF currently recommends flucloxacillin or clindamycin if penicillin allergic

antibiotic treatment is normally be given for several weeks (BNF states 6-12 weeks)

needle aspiration should be used to decompress the joint

arthroscopic lavage may be required

Overview

most common organism overall is Staphylococcus aureus

in young adults who are sexually active Neisseria gonorrhoeae should also be considered

in adults, the most common location is the knee

The Kocher criteria for the diagnosis of septic arthritis:

fever >38.5 degrees C

non-weight bearing

raised ESR

Kocher’s criteria is used to assess the probability of septic arthritis in children

Importance: 68

Kocher’s criteria is used to assess the probability of septic arthritis in children using 4 parameters:

Non-weight bearing - 1 point

Fever >38.5ºC - 1 point

WCC >12 * 109/L - 1 point

ESR >40mm/hr

The probabilities are calculated thus:

0 points = very low risk

1 point = 3% probability of septic arthritis

2 points = 40% probability of septic arthritis

3 points = 93% probability of septic arthritis

4 points = 99% probability of septic arthritis

This girl scores 0, and with a history of recent viral infection, the likely culprit is transient synovitis.

Juvenile idiopathic arthritis (JIA) is more likely to give a polyarticular presentation with systemic features, including fever and rashes.

There is no indication of psoriasis in the presentation, making psoriatic arthritis unlikely.

Osteochondritis dissecans occurs when small segments of articular cartilage and bone come loose into the joint due to reduced blood supply. It tends to present in older children with a more insidious onset.

Radial tunnel syndrome presents similarly to lateral epicondylitis however pain is typically distal to the epicondyle and worse on elbow extension/forearm pronation

Importance: 54

Radial tunnel syndrome can be difficult to distinguish from lateral epicondylitis as both conditions present with lateral elbow pain. Radial tunnel syndrome however typically presents with tenderness distal to the common extensor origin in comparison to lateral epicondylitis where there is pain over the common extensor origin. It is most common in gymnasts, racquet players and golfers who frequently hyperextend at the wrist or carry out frequent supination/pronation. Patients can also complain of hand paraesthesia or aching at the wrist.

Cubital tunnel syndrome patients experience tingling and numbness in the 4th and 5th finger.

In olecranon bursitis, there would be presence of swelling over the posterior elbow.

Cervical radiculopathy would cause a burning pain radiating from shoulder to fingers. There may be reduced cervical range of motion or pain as clues in the history.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Marfan’s syndrome

A

Marfan’s syndrome is an autosomal dominant connective tissue disorder. It is caused by a defect in the FBN1 gene on chromosome 15 that codes for the protein fibrillin-1. It affects around 1 in 3,000 people.

Features

tall stature with arm span to height ratio > 1.05

high-arched palate

arachnodactyly

pectus excavatum

pes planus

scoliosis of > 20 degrees

heart: dilation of the aortic sinuses (seen in 90%) which may lead to aortic aneurysm, aortic dissection, aortic regurgitation, mitral valve prolapse (75%),
lungs: repeated pneumothoraces
eyes: upwards lens dislocation (superotemporal ectopia lentis), blue sclera, myopia

dural ectasia (ballooning of the dural sac at the lumbosacral level)

The life expectancy of patients used to be around 40-50 years. With the advent of regular echocardiography monitoring and beta-blocker/ACE-inhibitor therapy this has improved significantly over recent years. Aortic dissection and other cardiovascular problems remain the leading cause of death however.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Osteoarthritis diagnosis

A

Osteoarthritis diagnosis

NICE recommend that we can diagnose osteoarthritis clinically without the need for investigations if:

patient is > 45 years

has exercise related pain

no morning stiffness or morning stiffness lasting > 30 minutes

Osteoarthritis of the hands usually occurs as part of nodal osteoarthritis (a form of osteoarthritis that is usually genetic).

It results in the formation of:

Heberden’s nodes - swelling of the distal interphalangeal joints.
Bouchard’s nodes - swelling of proximal interphalangeal joints

No treatment is needed for these.

Source: http://www.arthritisresearchuk.org/arthritis-information/conditions/osteoarthritis/which-joints-are-affected/hands.aspx

Pyogenic granuloma is a bright red/blood crusted lesion that usually occurs follow trauma. It is more common in children.

A ganglion is subcutaneous, cystic lesion of the joint or synovial sheath of a tendon. It most commonly occurs at the wrist.

A sebaceous cyst is a round, mobile cyst with a characteristic central punctum

Osteoarthritis: x-ray changes

X-ray changes of osteoarthritis

decrease of joint space

subchondral sclerosis

subchondral cysts

osteophytes forming at joint margins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Osteoarthritis: management

A

NICE published guidelines on the management of osteoarthritis (OA) in 2014

all patients should be offered help with weight loss, given advice about local muscle strengthening exercises and general aerobic fitness

paracetamol and topical NSAIDs are first-line analgesics. Topical NSAIDs are indicated only for OA of the knee or hand

second-line treatment is oral NSAIDs/COX-2 inhibitors, opioids, capsaicin cream and intra-articular corticosteroids. A proton pump inhibitor should be co-prescribed with NSAIDs and COX-2 inhibitors. These drugs should be avoided if the patient takes aspirin

non-pharmacological treatment options include supports and braces, TENS and shock absorbing insoles or shoes

if conservative methods fail then refer for consideration of joint replacement

What is the role of glucosamine?

normal constituent of glycosaminoglycans in cartilage and synovial fluid

a systematic review of several double blind RCTs of glucosamine in knee osteoarthritis reported significant short-term symptomatic benefits including significantly reduced joint space narrowing and improved pain scores

more recent studies have however been mixed

the 2008 NICE guidelines suggest it is not recommended

a 2008 Drug and Therapeutics Bulletin review advised that whilst glucosamine provides modest pain relief in knee osteoarthritis it should not be prescribed on the NHS due to limited evidence of cost-effectiveness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Osteoporosis management

A

Osteoporosis management

Advancing age and female sex are significant risk factors for osteoporosis. Prevalence of osteoporosis increases from 2% at 50 years to more than 25% at 80 years in women.

There are many other risk factors and secondary causes of osteoporosis. We’ll start by looking at the most ‘important’ ones - these are risk factors that are used by major risk assessment tools such as FRAX:

history of glucocorticoid use

rheumatoid arthritis

alcohol excess

history of parental hip fracture

low body mass index

current smoking

Other risk factors

sedentary lifestyle

premature menopause

Caucasians and Asians

endocrine disorders: hyperthyroidism, hypogonadism (e.g. Turner’s, testosterone deficiency), growth hormone deficiency, hyperparathyroidism, diabetes mellitus

multiple myeloma, lymphoma

gastrointestinal disorders: inflammatory bowel disease, malabsorption (e.g. Coeliac’s), gastrectomy, liver disease

chronic kidney disease

osteogenesis imperfecta, homocystinuria

Medications that may worsen osteoporosis (other than glucocorticoids):

SSRIs

antiepileptics

proton pump inhibitors

glitazones

long term heparin therapy

aromatase inhibitors e.g. anastrozole

Investigations for secondary causes

If a patient is diagnosed with osteoporosis or has a fragility fracture further investigations may be warranted. NOGG recommend testing for the following reasons:

exclude diseases that mimic osteoporosis (e.g. osteomalacia, myeloma);

identify the cause of osteoporosis and contributory factors;

assess the risk of subsequent fractures;

select the most appropriate form of treatment

The following investigations are recommended by NOGG:

History and physical examination

Blood cell count, sedimentation rate or C-reactive protein, serum calcium,

albumin, creatinine, phosphate, alkaline phosphatase and liver transaminases

Thyroid function tests

Bone densitometry ( DXA)

Other procedures, if indicated

Lateral radiographs of lumbar and thoracic spine/DXA-based vertebral imaging

Protein immunoelectrophoresis and urinary Bence-Jones proteins

25OHD

PTH

Serum testosterone, SHBG, FSH, LH (in men),

Serum prolactin

24 hour urinary cortisol/dexamethasone suppression test

Endomysial and/or tissue transglutaminase antibodies (coeliac disease)

Isotope bone scan

Markers of bone turnover, when available

Urinary calcium excretion

So from the first list we should order the following bloods as a minimum for all patients:

full blood count

urea and electrolytes

liver function tests

bone profile

CRP

thyroid function tests

18
Q

Osteoporotic Treatment

A

NICE guidelines were updated in 2008 on the secondary prevention of osteoporotic fractures in postmenopausal women.

Key points include

treatment is indicated following osteoporotic fragility fractures in postmenopausal women who are confirmed to have osteoporosis (a T-score of - 2.5 SD or below). In women aged 75 years or older, a DEXA scan may not be required ‘if the responsible clinician considers it to be clinically inappropriate or unfeasible’

vitamin D and calcium supplementation should be offered to all women unless the clinician is confident they have adequate calcium intake and are vitamin D replete

alendronate is first-line

around 25% of patients cannot tolerate alendronate, usually due to upper gastrointestinal problems. These patients should be offered risedronate or etidronate (see treatment criteria below)

strontium ranelate and raloxifene are recommended if patients cannot tolerate bisphosphonates (see treatment criteria below)

Treatment criteria for patients not taking alendronate

Unfortunately, a number of complicated treatment cut-off tables have been produced in the latest guidelines for patients who do not tolerate alendronate

These take into account a patients age, theire T-score and the number of risk factors they have from the following list:

parental history of hip fracture

alcohol intake of 4 or more units per day

rheumatoid arthritis

It is very unlikely that examiners would expect you to have memorised these risk tables so we’ve not included them in the revision notes but they may be found by following the NICE link. The most important thing to remember is:

the T-score criteria for risedronate or etidronate are less than the others implying that these are the second line drugs

if alendronate, risedronate or etidronate cannot be taken then strontium ranelate or raloxifene may be given based on quite strict T-scores (e.g. a 60-year-old woman would need a T-score < -3.5)

the strictest criteria are for denosumab

Supplementary notes on treatment

Bisphosphonates

alendronate, risedronate and etidronate are all licensed for the prevention and treatment of post-menopausal and glucocorticoid-induced osteoporosis

all three have been shown to reduce the risk of both vertebral and non-vertebral fractures although alendronate, risedronate may be superior to etidronate in preventing hip fractures

ibandronate is a once-monthly oral bisphosphonate

Vitamin D and calcium

poor evidence base to suggest reduced fracture rates in the general population at risk of osteoporotic fractures - may reduce rates in frail, housebound patients

Raloxifene - selective oestrogen receptor modulator (SERM)

has been shown to prevent bone loss and to reduce the risk of vertebral fractures, but has not yet been shown to reduce the risk of non-vertebral fractures

has been shown to increase bone density in the spine and proximal femur

may worsen menopausal symptoms

increased risk of thromboembolic events

may decrease risk of breast cancer

Strontium ranelate

‘dual action bone agent’ - increases deposition of new bone by osteoblasts (promotes differentiation of pre-osteoblast to osteoblast) and reduces the resorption of bone by inhibiting osteoclasts

concerns regarding the safety profile of strontium have been raised recently. It should only be prescribed by a specialist in secondary care

due to these concerns the European Medicines Agency in 2014 said it should only be used by people for whom there are no other treatments for osteoporosis

increased risk of cardiovascular events: any history of cardiovascular disease or significant risk of cardiovascular disease is a contraindication

increased risk of thromboembolic events: a Drug Safety Update in 2012 recommended it is not used in patients with a history of venous thromboembolism

may cause serious skin reactions such as Stevens Johnson syndrome

Denosumab

human monoclonal antibody that inhibits RANK ligand, which in turn inhibits the maturation of osteoclasts

given as a single subcutaneous injection every 6 months

initial trial data suggests that it is effective and well tolerated

Teriparatide

recombinant form of parathyroid hormone

very effective at increasing bone mineral density but role in the management of osteoporosis yet to be clearly defined

Hormone replacement therapy

has been shown to reduce the incidence of vertebral fracture and non-vertebral fractures

due to concerns about increased rates of cardiovascular disease and breast cancer it is no longer recommended for primary or secondary prevention of osteoporosis unless the woman is suffering from vasomotor symptoms

Hip protectors

evidence to suggest significantly reduce hip fractures in nursing home patients

compliance is a problem

Falls risk assessment

no evidence to suggest reduced fracture rates

however, do reduce rate of falls and should be considered in management of high risk patients

19
Q

Pagets disease of the bone

A

Paget’s disease is a disease of increased but uncontrolled bone turnover. It is thought to be primarily a disorder of osteoclasts, with excessive osteoclastic resorption followed by increased osteoblastic activity. Paget’s disease is common (UK prevalence 5%) but symptomatic in only 1 in 20 patients. The skull, spine/pelvis, and long bones of the lower extremities are most commonly affected.

Predisposing factors

increasing age

male sex

northern latitude

family history

Clinical features - only 5% of patients are symptomatic

the stereotypical presentation is an older male with bone pain and an isolated raised ALP

bone pain (e.g. pelvis, lumbar spine, femur)

classical, untreated features: bowing of tibia, bossing of skull

raised alkaline phosphatase (ALP) - calcium* and phosphate are typically normal

other markers of bone turnover include: procollagen type I N-terminal propeptide (PINP), serum C-telopeptide (CTx), urinary N-telopeptide (NTx), and urinary hydroxyproline

skull x-ray: thickened vault, osteoporosis circumscripta

Indications for treatment include bone pain, skull or long bone deformity, fracture, periarticular Paget’s

bisphosphonate (either oral risedronate or IV zoledronate)

calcitonin is less commonly used now

Complications

deafness (cranial nerve entrapment)

bone sarcoma (1% if affected for > 10 years)

fractures

skull thickening

high-output cardiac failure

20
Q

Polymyalgia rheumatica

A

Pathophysiology overlaps with temporal arteritis

histology shows vasculitis with giant cells, characteristically ‘skips’ certain sections of affected artery whilst damaging others

muscle bed arteries affected most in polymyalgia rheumatica

Features

typically patient > 60 years old

usually rapid onset (e.g. < 1 month)

aching, morning stiffness in proximal limb muscles (not weakness)

also mild polyarthralgia, lethargy, depression, low-grade fever, anorexia, night sweats

Investigations

ESR > 40 mm/hr

note creatine kinase and EMG normal

Treatment

prednisolone e.g. 15mg/od - dramatic response

21
Q

Psoriatic arthropathy

A

Psoriatic arthropathy correlates poorly with cutaneous psoriasis and often precedes the development of skin lesions. Around 10-20% percent of patients with skin lesions develop an arthropathy with males and females being equally affected

Types*

rheumatoid-like polyarthritis: (30-40%, most common type)

asymmetrical oligoarthritis: typically affects hands and feet (20-30%)

sacroilitis

DIP joint disease (10%)

arthritis mutilans (severe deformity fingers/hand, ‘telescoping fingers’)

Management

should be managed by a rheumatologist

treat as rheumatoid arthritis but better prognosis

22
Q

Raynauds

A

Raynaud’s phenomena may be primary (Raynaud’s disease) or secondary (Raynaud’s phenomenon)

Raynaud’s disease typically presents in young women (e.g. 30 years old) with bilateral symptoms.

Factors suggesting underlying connective tissue disease

onset after 40 years

unilateral symptoms

rashes

presence of autoantibodies

features which may suggest rheumatoid arthritis or SLE, for example arthritis or recurrent miscarriages

digital ulcers, calcinosis

very rarely: chilblains

Secondary causes

connective tissue disorders: scleroderma (most common), rheumatoid arthritis, SLE

leukaemia

type I cryoglobulinaemia, cold agglutinins

use of vibrating tools

drugs: oral contraceptive pill, ergot

cervical rib

Management

first-line: calcium channel blockers e.g. nifedipine

IV prostacyclin (epoprostenol) infusions: effects may last several weeks/months

23
Q

Antiphospholipid syndrome

A

Antiphospholipid syndrome is an acquired disorder characterised by a predisposition to both venous and arterial thromboses, recurrent fetal loss and thrombocytopenia. It may occur as a primary disorder or secondary to other conditions, most commonly systemic lupus erythematosus (SLE)

A key point for the exam is to appreciate that antiphospholipid syndrome causes a paradoxical rise in the APTT. This is due to an ex-vivo reaction of the lupus anticoagulant autoantibodies with phospholipids involved in the coagulation cascade

Features

venous/arterial thrombosis

recurrent fetal loss

livedo reticularis

thrombocytopenia

prolonged APTT

other features: pre-eclampsia, pulmonary hypertension

Associations other than SLE

other autoimmune disorders

lymphoproliferative disorders

phenothiazines (rare)

Management - based on BCSH guidelines

initial venous thromboembolic events: evidence currently supports use of warfarin with a target INR of 2-3 for 6 months

recurrent venous thromboembolic events: lifelong warfarin; if occurred whilst taking warfarin then increase target INR to 3-4

arterial thrombosis should be treated with lifelong warfarin with target INR 2-3

24
Q

Chronic fatigue syndrome

A

Diagnosed after at least 4 months of disabling fatigue affecting mental and physical function more than 50% of the time in the absence of other disease which may explain symptoms

Epidemiology

more common in females

past psychiatric history has not been shown to be a risk factor

Fatigue is the central feature, other recognised features include

sleep problems, such as insomnia, hypersomnia, unrefreshing sleep, a disturbed sleep-wake cycle

muscle and/or joint pains

headaches

painful lymph nodes without enlargement

sore throat

cognitive dysfunction, such as difficulty thinking, inability to concentrate, impairment of short-term memory, and difficulties with word-finding

physical or mental exertion makes symptoms worse

general malaise or ‘flu-like’ symptoms

dizziness

nausea

palpitations

Investigation

NICE guidelines suggest carrying out a large number of screening blood tests to exclude other pathology e.g. FBC, U&E, LFT, glucose, TFT, ESR, CRP, calcium, CK, ferritin*, coeliac screening and also urinalysis

Management

cognitive behaviour therapy - very effective, number needed to treat = 2

graded exercise therapy - a formal supervised program, not advice to go to the gym

‘pacing’ - organising activities to avoid tiring

low-dose amitriptyline may be useful for poor sleep

referral to a pain management clinic if pain is a predominant feature

Better prognosis in children

25
Q

Reactive arthritis features

A

Reactive arthritis is one of the HLA-B27 associated seronegative spondyloarthropathies. It encompasses Reiter’s syndrome, a term which described a classic triad of urethritis, conjunctivitis and arthritis following a dysenteric illness during the Second World War. Later studies identified patients who developed symptoms following a sexually transmitted infection (post-STI, now sometimes referred to as sexually acquired reactive arthritis, SARA).

Reactive arthritis is defined as an arthritis that develops following an infection where the organism cannot be recovered from the joint.

Features

typically develops within 4 weeks of initial infection - symptoms generally last around 4-6 months

arthritis is typically an asymmetrical oligoarthritis of lower limbs

dactylitis

symptoms of urethritis

eye: conjunctivitis (seen in 10-30%), anterior uveitis
skin: circinate balanitis (painless vesicles on the coronal margin of the prepuce), keratoderma blenorrhagica (waxy yellow/brown papules on palms and soles)

Around 25% of patients have recurrent episodes whilst 10% of patients develop chronic disease

‘Can’t see, pee or climb a tree’

26
Q

Rheumatoid arthritis drug side-effects

A

The table below lists some of the characteristic (if not common) side-effects of drugs used to treat rheumatoid arthritis:

Drug

Side-effects

Methotrexate

Myelosuppression
Liver cirrhosis
Pneumonitis

Sulfasalazine

Rashes
Oligospermia
Heinz body anaemia
Interstitial lung disease

Leflunomide

Liver impairment
Interstitial lung disease
Hypertension

Hydroxychloroquine

Retinopathy
Corneal deposits

Prednisolone

Cushingoid features
Osteoporosis
Impaired glucose tolerance
Hypertension
Cataracts

Gold

Proteinuria

Penicillamine

Proteinuria
Exacerbation of myasthenia gravis

Etanercept

Demyelination
Reactivation of tuberculosis

Infliximab

Reactivation of tuberculosis

Adalimumab

Reactivation of tuberculosis

Rituximab

Infusion reactions are common

NSAIDs (e.g. naproxen, ibuprofen)

Bronchospasm in asthmatics
Dyspepsia/peptic ulceration

27
Q

Rheumatoid arthritis: prognostic features

A

A number of features have been shown to predict a poor prognosis in patients with rheumatoid arthritis, as listed below

Poor prognostic features

rheumatoid factor positive

poor functional status at presentation

HLA DR4

X-ray: early erosions (e.g. after < 2 years)

extra articular features e.g. nodules

insidious onset

anti-CCP antibodies

In terms of gender there seems to be a split in what the established sources state is associated with a poor prognosis. However both the American College of Rheumatology and the recent NICE guidelines (which looked at a huge number of prognosis studies) seem to conclude that female gender is associated with a poor prognosis.

28
Q

Septic arthritis

A

Overview

most common organism overall is Staphylococcus aureus

in young adults who are sexually active Neisseria gonorrhoeae should also be considered

in adults, the most common location is the knee

The Kocher criteria for the diagnosis of septic arthritis:

fever >38.5 degrees C

non-weight bearing

raised ESR

raised WCC

Management

synovial fluid should be obtained before starting treatment

intravenous antibiotics which cover Gram-positive cocci are indicated. The BNF currently recommends flucloxacillin or clindamycin if penicillin allergic

antibiotic treatment is normally be given for several weeks (BNF states 6-12 weeks)

needle aspiration should be used to decompress the joint

arthroscopic lavage may be required

29
Q

Rotator cuff muscles

A

SItS - small t for teres minor

Supraspinatus
Infraspinatus
teres minor
Subscapularis

Muscle

Notes

Supraspinatus

aBDucts arm before deltoid
Most commonly injured

Infraspinatus

Rotates arm laterally

teres minor

aDDucts & rotates arm laterally

Subscapularis

aDDuct & rotates arm medially

30
Q

Sjogren’s syndrome

A

Sjogren’s syndrome is an autoimmune disorder affecting exocrine glands resulting in dry mucosal surfaces. It may be primary (PSS) or secondary to rheumatoid arthritis or other connective tissue disorders, where it usually develops around 10 years after the initial onset. Sjogren’s syndrome is much more common in females (ratio 9:1). There is a marked increased risk of lymphoid malignancy (40-60 fold).

Features

dry eyes: keratoconjunctivitis sicca

dry mouth

vaginal dryness

arthralgia

Raynaud’s, myalgia

sensory polyneuropathy

recurrent episodes of parotitis

renal tubular acidosis (usually subclinical)

Investigation

rheumatoid factor (RF) positive in nearly 100% of patients

ANA positive in 70%

anti-Ro (SSA) antibodies in 70% of patients with PSS

anti-La (SSB) antibodies in 30% of patients with PSS

Schirmer’s test: filter paper near conjunctival sac to measure tear formation

histology: focal lymphocytic infiltration
also: hypergammaglobulinaemia, low C4

Management

artificial saliva and tears

pilocarpine may stimulate saliva production

31
Q

Raynaud’s

A

Raynaud’s phenomena may be primary (Raynaud’s disease) or secondary (Raynaud’s phenomenon)

Raynaud’s disease typically presents in young women (e.g. 30 years old) with bilateral symptoms.

Factors suggesting underlying connective tissue disease

onset after 40 years

unilateral symptoms

rashes

presence of autoantibodies

features which may suggest rheumatoid arthritis or SLE, for example arthritis or recurrent miscarriages

digital ulcers, calcinosis

very rarely: chilblains

Secondary causes

connective tissue disorders: scleroderma (most common), rheumatoid arthritis, SLE

leukaemia

type I cryoglobulinaemia, cold agglutinins

use of vibrating tools

drugs: oral contraceptive pill, ergot

cervical rib

Management

first-line: calcium channel blockers e.g. nifedipine

IV prostacyclin (epoprostenol) infusions: effects may last several weeks/months

32
Q

Systemic sclerosis

A

This patient has Sclerodactyly and Raynaud’s phenomenon. Telangiectasia can also be seen on the hands. She therefore has the RST of CREST syndrome, or more accurately limited cutaneous systemic sclerosis.

Systemic sclerosis is a condition of unknown aetiology characterised by hardened, sclerotic skin and other connective tissues. It is four times more common in females.

There are three patterns of disease:

Limited cutaneous systemic sclerosis

Raynaud’s may be first sign

scleroderma affects face and distal limbs predominately

associated with anti-centromere antibodies

a subtype of limited systemic sclerosis is CREST syndrome: Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, Telangiectasia

Diffuse cutaneous systemic sclerosis

scleroderma affects trunk and proximal limbs predominately

associated with scl-70 antibodies

the most common cause of death is now respiratory involvement, which is seen in around 80%: interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH)

other complications include renal disease and hypertension

poor prognosis

Scleroderma (without internal organ involvement)

tightening and fibrosis of skin

may be manifest as plaques (morphoea) or linear

33
Q

Polymyalgia rheumatica

A

Pathophysiology

overlaps with temporal arteritis

histology shows vasculitis with giant cells, characteristically ‘skips’ certain sections of affected artery whilst damaging others

muscle bed arteries affected most in polymyalgia rheumatica

Features

typically patient > 60 years old

usually rapid onset (e.g. < 1 month)

aching, morning stiffness in proximal limb muscles (not weakness)

also mild polyarthralgia, lethargy, depression, low-grade fever, anorexia, night sweats

Investigations

ESR > 40 mm/hr

note creatine kinase and EMG normal

Treatment

prednisolone e.g. 15mg/od - dramatic response

34
Q

Temporal arteritis

A

Temporal arteritis is large vessel vasculitis which overlaps with polymyalgia rheumatica (PMR). Histology shows changes which characteristically ‘skips’ certain sections of affected artery whilst damaging others.

Features

typically patient > 60 years old

usually rapid onset (e.g. < 1 month)

headache (found in 85%)

jaw claudication (65%)

visual disturbances secondary to anterior ischemic optic neuropathy

tender, palpable temporal artery

around 50% have features of PMR: aching, morning stiffness in proximal limb muscles (not weakness)

also lethargy, depression, low-grade fever, anorexia, night sweats

Investigations

raised inflammatory markers: ESR > 50 mm/hr (note ESR < 30 in 10% of patients). CRP may also be elevated

temporal artery biopsy: skip lesions may be present

note creatine kinase and EMG normal

Treatment

high-dose prednisolone - there should be a dramatic response, if not the diagnosis should be reconsidered

urgent ophthalmology review. Patients with visual symptoms should be seen the same-day by an ophthalmologist. Visual damage is often irreversible

35
Q

Osteomalacia

A

Basics

normal bony tissue but decreased mineral content

rickets if when growing

osteomalacia if after epiphysis fusion

Types

vitamin D deficiency e.g. malabsorption, lack of sunlight, diet

renal failure

drug induced e.g. anticonvulsants

vitamin D resistant; inherited

liver disease, e.g. cirrhosis

Features

rickets: knock-knee, bow leg, features of hypocalcaemia
osteomalacia: bone pain, fractures, muscle tenderness, proximal myopathy

Investigation

low 25(OH) vitamin D (in 100% of patients, by definition)

raised alkaline phosphatase (in 95-100% of patients)

low calcium, phosphate (in around 30%)

x-ray: children - cupped, ragged metaphyseal surfaces; adults - translucent bands (Looser’s zones or pseudofractures)

Treatment

calcium with vitamin D tablets

36
Q

Polymyalgia rheumatica

A

Pathophysiology

overlaps with temporal arteritis

histology shows vasculitis with giant cells, characteristically ‘skips’ certain sections of affected artery whilst damaging others

muscle bed arteries affected most in polymyalgia rheumatica

Features

typically patient > 60 years old

usually rapid onset (e.g. < 1 month)

aching, morning stiffness in proximal limb muscles (not weakness)

also mild polyarthralgia, lethargy, depression, low-grade fever, anorexia, night sweats

Investigations

ESR > 40 mm/hr

note creatine kinase and EMG normal

Treatment

prednisolone e.g. 15mg/od - dramatic response

37
Q

Reactive arthritis: features

A

Reactive arthritis is one of the HLA-B27 associated seronegative spondyloarthropathies. It encompasses Reiter’s syndrome, a term which described a classic triad of urethritis, conjunctivitis and arthritis following a dysenteric illness during the Second World War. Later studies identified patients who developed symptoms following a sexually transmitted infection (post-STI, now sometimes referred to as sexually acquired reactive arthritis, SARA).

Reactive arthritis is defined as an arthritis that develops following an infection where the organism cannot be recovered from the joint.

Features

typically develops within 4 weeks of initial infection - symptoms generally last around 4-6 months

arthritis is typically an asymmetrical oligoarthritis of lower limbs

dactylitis

symptoms of urethritis

eye: conjunctivitis (seen in 10-30%), anterior uveitis
skin: circinate balanitis (painless vesicles on the coronal margin of the prepuce), keratoderma blenorrhagica (waxy yellow/brown papules on palms and soles)

Around 25% of patients have recurrent episodes whilst 10% of patients develop chronic disease

‘Can’t see, pee or climb a tree’

38
Q

Temporal arteritis

A

Temporal arteritis is large vessel vasculitis which overlaps with polymyalgia rheumatica (PMR). Histology shows changes which characteristically ‘skips’ certain sections of affected artery whilst damaging others.

Features

typically patient > 60 years old

usually rapid onset (e.g. < 1 month)

headache (found in 85%)

jaw claudication (65%)

visual disturbances secondary to anterior ischemic optic neuropathy

tender, palpable temporal artery

around 50% have features of PMR: aching, morning stiffness in proximal limb muscles (not weakness)

also lethargy, depression, low-grade fever, anorexia, night sweats

Investigations

raised inflammatory markers: ESR > 50 mm/hr (note ESR < 30 in 10% of patients). CRP may also be elevated

temporal artery biopsy: skip lesions may be present

note creatine kinase and EMG normal

Treatment

high-dose prednisolone - there should be a dramatic response, if not the diagnosis should be reconsidered

urgent ophthalmology review. Patients with visual symptoms should be seen the same-day by an ophthalmologist. Visual damage is often irreversible

39
Q

Vitamin D supplementation

A

Vitamin D supplementation has been a hot topic for a number of years now. The muddied waters are now slightly clearer following the release of the following:

2012: letter by the Chief Medical Officer regarding vitamin D supplementation
2013: National Osteoporosis Society (NOS) release UK Vitamin D guideline

The following groups should be advised to take vitamin D supplementation:

all pregnant and breastfeeding women should take a daily supplement containing 10µg of vitamin D

all children aged 6 months - 5 years. Babies fed with formula milk do not need to take a supplement if they are taking more than 500ml of milk a day, as formula milk is fortified with vitamin D

adults > 65 years

‘people who are not exposed to much sun should also take a daily supplement’ e.g. housebound patients

Testing for vitamin D deficiency

The key message is that not many people warrant a vitamin D test. The NOS guidelines specify that testing may be appropriate in the following situtations:

patients with bone diseases that may be improved with vitamin D treatment e.g. known osteomalacia or Paget’s disease

patients with bone diseases, prior to specific treatment where correcting vitamin deficiency is appropriate e,g, prior to intravenous zolendronate or denosumab

patients with musculoskeletal symptoms that could be attributed to vitamin D deficiency e.g. bone pain ?osteomalacia

Patients with osteoporosis should always be given calcium/vitamin D supplements so testing is not considered necessary. People who are at higher risk of vitamin D deficiency (see above) should be treated anyway so again testing is not necessary.

40
Q
A